We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Manual to Help Clinicians Better Diagnose and Treat Infection-Associated Chronic Illness

By LabMedica International staff writers
Posted on 20 Aug 2025

Infection-associated chronic illnesses (IACIs) such as long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and long Lyme disease are disabling, costly, and often misunderstood in medicine. More...

Millions of people worldwide live with these conditions, which are difficult to diagnose due to the absence of definitive biomarkers and complex symptom profiles. Despite rising cases, knowledge gaps and stigma persist, leaving many patients without adequate care. To address these challenges, a new resource has been created to equip clinicians with evidence-based practices and improve patient outcomes.

Mount Sinai Health System (New York, NY, USA) has introduced the first clinical manual in the US for treating IACIs, developed by the Cohen Center for Recovery from Complex Chronic Illnesses (New York, NY, USA). The guide incorporates extensive learnings from the Center’s clinical care and research programs, which lead trials for promising therapies and investigate the similarities and differences among patients with these conditions. The manual provides comprehensive instruction on diagnosis, long-term management strategies, multidisciplinary care models, and effective patient communication.

Drawing from the Center’s infrastructure and treatment approaches, the manual details infection prevention protocols such as the use of HEPA filters and germicidal far-UV light technology to minimize exposure during in-person visits. It also outlines physical therapy guidelines for conditions including Ehlers-Danlos syndrome, dysautonomia, and craniocervical instability. Importantly, it warns against incorrectly prescribed cardiovascular exercise, which may harm patients experiencing post-exertional malaise.

The manual covers the care of common manifestations like brain fog, mast cell activation, and post-exertional malaise, while also presenting a molecular-level perspective on the biological processes behind diverse clinical presentations. These insights help explain why certain symptoms arise and provide clinicians with tools to develop targeted care strategies.

Reviewed by more than a dozen national and international experts, the manual ensures global relevance and practical usability. Going forward, Mount Sinai plans to support clinicians worldwide by making the manual freely accessible online. In addition, the Center will provide supplementary resources such as CME-accredited courses, events, and educational programs to strengthen adoption.

“Infection-associated chronic illnesses remain disabling, costly, and widely misunderstood across much of medicine,” said Raven Baxter, PhD, Director of Science Communication at the Cohen Center for Recovery from Complex Chronic Illnesses at Mount Sinai. “Recent research from our team shows that even a single well-designed educational intervention can dramatically increase clinicians’ confidence, preparedness, and empathy in managing these conditions.”

Related Links:
Mount Sinai Health System
Cohen Center for Recovery from Complex Chronic Illnesses


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Steam Sterilizer
Hi Vac II Line
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.